Ginkgo Bioworks Holdings Inc (NYSE:DNA)
$ 0.934 -0.0541 (-5.48%) Market Cap: 2.06 Bil Enterprise Value: 1.47 Bil PE Ratio: 0 PB Ratio: 1.80 GF Score: 17/100

Q2 2022 Ginkgo Bioworks Holdings Inc Earnings Call Transcript

Aug 15, 2022 / 08:30PM GMT
Release Date Price: $3.49 (-3.86%)
Anna Marie Wagner;Jason Kelly
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development;Ginkgo Bioworks Holdings,

Good afternoon. This is Anna Marie Wagner, SVP of Corporate Development at Ginkgo Bioworks. As usual, I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO. We thank you for joining us and look forward to providing you with an update on the last quarter.

As a reminder, during the presentation today, we'll be making forward-looking statements, which involve risks and uncertainties. Please refer to our filings with the Securities and Exchange Commission to learn more about these risks and uncertainties. We'll follow our standard agenda for these calls, providing an update on our financial progress while also taking time to dig deeper on our strategic priorities. We'll end with a Q&A session, and I'll take questions from analysts, investors and the public. As usual, you can submit those questions to us in advance via Twitter #GinkgoResults or e-mail at [email protected].

All right. Over to you, Jason.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot